Recommended Dexamethasone Dosages for CINV in Southeast Asia | Download Table
Cardiac Considerations for Modern Multiple Myeloma Therapies - American College of Cardiology
Antiemetic Dosing by Chemotherapy Risk Category* | Download Table
Article: Drug-drug interactions with aprepitant in antiemetic prophylaxis for chemotherapy (full text) - April 2018 - NJM
Corticosteroid doses for common indications in cancer patients | Download Table
Single-dose Palonosetron and Dose-reduced Regimen of Dexamethasone in Preventing Nausea and Vomiting by Anthracycline-including Chemotherapy in Patients with Early Breast Cancer | Anticancer Research
Dexamethasone-Sparing Strategies Using Netupitant and Palonosetron Fixed- Dose Combination for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting: A Case Series
Incidence of chemotherapy-induced nausea and vomiting associated with docetaxel and cyclophosphamide in early breast cancer patients and aprepitant efficacy as salvage therapy. Results from the Spanish Breast Cancer Group/2009-02 study - ScienceDirect
Study Supports Low-Dose Dexamethasone as Premedication for Taxanes - Cancer Therapy Advisor
![PDF] Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/25e014c7f0853656f4bd8a4776cb3ed042eada3d/3-Table1-1.png "PDF] Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy. | Semantic Scholar")
PDF] Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy. | Semantic Scholar
Rolapitant - wikidoc
Dexamethasone-Sparing Strategies Using Netupitant and Palonosetron Fixed- Dose Combination for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting: A Case Series
Dexamethasone-Sparing Strategies Using Netupitant and Palonosetron Fixed- Dose Combination for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting: A Case Series
Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma | NEJM
Dexamethasone dosing for prevention of acute chemotherapy‐induced vomiting in pediatric patients: A systematic review - Patel - 2020 - Pediatric Blood & Cancer - Wiley Online Library
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial - The Lancet Oncology
Corticosteroids in the Treatment of Chemotherapy-Induced Nausea and Vomiting in: Journal of the National Comprehensive Cancer Network Volume 10 Issue 4 (2012)
Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma | British Journal of Cancer
Pregnancy-Associated Breast Cancer
Dexamethasone-Sparing Strategies Using Netupitant and Palonosetron Fixed- Dose Combination for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting: A Case Series
Cheaper Options in the Prevention of Chemotherapy-Induced Nausea and Vomiting | JCO Global Oncology
IJMS | Free Full-Text | High-Dose Dexamethasone Manipulates the Tumor Microenvironment and Internal Metabolic Pathways in Anti-Tumor Progression
Dexamethasone (6 mg/m2/day) and prednisolone (60 mg/m2/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial | Haematologica
Single-dose dexamethasone for the prevention of pemetrexed associated cutaneous adverse reactions | Semantic Scholar
Timing of AC chemotherapy, dexamethasone dosing, and PCP diagnosis on a... | Download Scientific Diagram
Fosaprepitant - wikidoc
